Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features

BackgroundHypertrophic cardiomyopathy (HCM) is a widely distributed, but clinically heterogeneous genetic heart disease, affects approximately 20 million people worldwide. Nowadays, HCM is treatable with the advancement of medical interventions. However, due to occult clinical presentations and a la...

Full description

Bibliographic Details
Main Authors: Lanyan Guo, Chao Gao, Weiping Yang, Zhiling Ma, Mengyao Zhou, Jianzheng Liu, Hong Shao, Bo Wang, Guangyu Hu, Hang Zhao, Ling Zhang, Xiong Guo, Chong Huang, Zhe Cui, Dandan Song, Fangfang Sun, Liwen Liu, Fuyang Zhang, Ling Tao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.889523/full